PET报告基因显像

陈虞梅; 黄钢

PET报告基因显像

陈虞梅 , 黄钢

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 3: (139-141)

引用本文:

Citation:

PET报告基因显像

陈虞梅¹,
黄钢²

1. 200127 上海, 上海交通大学医学院附属仁济医院核医学科;
2. 200127 上海, 上海交通大学医学院附属仁济医院临床核医学研究所
基金项目:
上海市科委重点基金项目(02DJ14037)

上海市百人计划第三轮重点资助项目(97BR012)
中图分类号: R817.4

Investigation progress of PET reporter gene imaging

CHEN Yu-mei¹,
HUANG Gang²

1. Department of Nuclear Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200127, China;
2. Institute of Nuclear Medicine, Shanghai Jiaotong University, Shanghai, 200127, China
CLC number: R817.4

摘要: 运用正电子发射体层显像(PET)及相关的PET报告基因及报告探针的活体显像技术可提供关于基因治疗定量及定性的信息,并可提供其他技术不能获得的参数,这对更好地理解基因治疗的过程及人类基因治疗的未来发展及临床应用很有意义。
- 体层摄影术,发射型计算机 /
- 基因,报告
Abstract: Molecular imaging for gene therapy and gene expression has been more and more attractive, while the use of gene therapy has been widely investigated and intense research have allowed it to the clinical setting in the last two-decade years. In vivo imaging with positron emission tomography (PET) by combination of appropriate PET reporter gene and PET reporter probe could provide qualitative and quantitative information for gene therapy. PET imaging could also obtain some valuable parameters not available by other techniques. This technology is useful to understand the process and development of gene therapy and how to apply it into clinical practice in the future.
- Tomography,emission-computed /
- Gene,reporter
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Penuelas I, Boan J, Marti-Climent JM, et al. Positron emission tomography and gene therapy:basic concepts and experimental approaches for in vivo gene expression imaging. Mol Imaging Biol,2004, 6(4):225-238.
[2]	Iyer M, Barrio JR, Namavari M, et al. 8-[18F]Fluoropenciclovir:an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med, 2001, 42(1):96-105.
[3]	Hospers GA, Calogero A, van Waarde A, et al. Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography. Cancer Res, 2000, 60(6):1488-1491.
[4]	Hustinx R, Shiue CY, Alasvi A, et al. Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and[18F]FHPG]. Eur J Nuel Med, 2001.28(1):5-12.
[5]	Alauddin MM, Shahinian A, Gordon EM, et al. Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.J Nucl Med, 2001, 42(11):1682-1690.
[6]	Alauddin MM, Shahinian A, Gordon EM, et al. Evaluation of 2'-deoxy-2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-TK expression in vivo. Mol Imaging,2002, 1(2):74-81.
[7]	Tjuvajev JG, Doubrovin M, Akhtwst T, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSVI-TK gene expression. J Nucl Med, 2002, 43(8):1072-1083.
[8]	Yaghoubi S, Barrio JR, Dahlbom M, et al. Human pharmacokinetic and dosimetry studies of[(18)F]FHBG:a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med, 2001,42(8):1225-1234.
[9]	Gambhir SS, Bauer E, Black ME, et al. A mutant herpes simplex virus type 1 thymidine kinase gene expression with positron emission with positron emission tomography. Proc Natl Acad Sci USA, 2000, 97(6):2785-2790.
[10]	Liang Q, Satynmurthy N, Barrio JR, et al. Noninvasive, quantitative imaging, in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther, 2001, 8(19):1490-1498.
[11]	Wester H, Schottelius M, Scheidhauer K, et al. PET imaging of somatostatin receptors:design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Eur J Nacl Med Mol Imaging, 2003, 30(1):117-122.
[12]	Groot-Wassink T, Aboagye EO, Wang Y, et al. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther, 2004, 9(3):436-442.
[13]	Niu G, Krager KJ, Graham MM, et al. Noninvasive radiological imaging of pulmonary gene transfer and expression using the human sodium iodide symporter. Eur J Nucl Med Mol Imaging,2005, 32(5):534-540.

[1]	刘影 , 兰晓莉 , 张永学 . 单纯疱疹病毒1-胸苷激酶报告基因显像研究进展. 国际放射医学核医学杂志, 2007, 31(6): 329-333.
[2]	尹小花 , 张永学 . 心血管核医学分子影像研究进展. 国际放射医学核医学杂志, 2007, 31(5): 261-264.
[3]	李林法 . ¹⁸F-氟代脱氧葡萄糖正电子发射体层显像在感染与炎症病变中的应用. 国际放射医学核医学杂志, 2006, 30(1): 26-29.
[4]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[5]	李祖贵 . 轻度认知障碍的功能性神经影像学研究进展. 国际放射医学核医学杂志, 2006, 30(2): 76-79.
[6]	余丰文 , 冯彦林 , 贺小红 , 刘德军 , 温广华 , 袁建伟 . PET-CT与钼靶X线、B超定性诊断乳腺癌的临床对比研究. 国际放射医学核医学杂志, 2006, 30(3): 148-151.
[7]	王俊起 , 高硕 . PET评价骨转移瘤. 国际放射医学核医学杂志, 2006, 30(2): 87-90.
[8]	罗作明 , 吴华 . PET代谢显像剂¹¹C-乙酸盐在临床中的应用. 国际放射医学核医学杂志, 2007, 31(1): 25-27.
[9]	张悦 . ¹⁸F-氟脱氧葡萄糖PET和PET-CT在结直肠癌术后复发或转移中的应用价值. 国际放射医学核医学杂志, 2007, 31(1): 34-36.
[10]	夏伟 , 罗全勇 , 袁志斌 . PET-CT在肿瘤放射治疗中的应用. 国际放射医学核医学杂志, 2006, 30(6): 331-335.
[11]	杨吉刚 , 李春林 . ¹⁸F-氟脱氧葡萄糖PET及PET-CT在食管癌中的. 国际放射医学核医学杂志, 2007, 31(1): 31-33.
[12]	张锦明 , 田嘉禾 , 刘伯里 . 影响PET放射性药物¹¹C甲基化的因素. 国际放射医学核医学杂志, 2006, 30(5): 271-274.
[13]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.